CAJ | 학술논문

目的初步探索低阻抗意念导入疗法治疗抑郁症的心理机制.方法将60例抑郁症患者随机分为低阻抗状态下的意念导入疗法组(TIP组)和氢溴酸西酞普兰片组(对照组),疗程6个月,采用汉密尔顿抑郁量表(HAMD)评定疗效,明尼苏达多项人格量表(MMPI)、五态人格量表评定作用机制.结果 MMPI量表中疑病[TIP组治疗前后分别为(70.33±12.50)分、(60.45±11.94)分,对照组为(66.41±11.74)分、(57.95±11.66)分]、抑郁[TIP组治疗前后分别为(71.62±8.81)分、(61.45±11.13)分,对照组为(66.75±12.34)分、(54.75±11.80)分]、癔病[TIP组治疗前后分别为(71.75±8.32)分、(64.87±8.58)分,对照组为(67.70±9.51)分、(59.33±9.89)分]、精神病态[TIP治疗前后分别为(69.41±10.31)分、(60.70±13.19)分,对照组为(62.83±12.93)分、(56.04±12.39)分]、偏执[TIP组治疗前后分别为(60.16±7.64)分、(53.83±7.92)分,对照组为(58.79±12.88)分、(51.48±10.46)分]、精神衰弱[TIP组治疗前后分别为(70.91±9.07)分、(63.45±9.53)分,对照组为(64.58±10.91)分、(53.25±15.64)分]、精神分裂[TIP组治疗前后分别为(64.08±12.28)分、(58.70±12.55)分,对照组为(58.75±14.93)分、(51.95±11.89)分]有显著改善作用.氢溴酸西酞普兰片在改善MMPI量表中精神衰弱、精神分裂(TPt=2.484、P=0.021;TSc=2.099、P=0.047)以及五态人格中太阳型、少阳型人格(T太阳=-2.175、P=0.040;T少阳=-2.066、P=0.049)方面优于TIP组.结论 TIP治疗抑郁症的心理机制在于改善MMPI量表中疑病、抑郁、癔病、精神病态、偏执、精神衰弱、精神分裂因子.
목적 초보탐색저조항의념도입요법치료억욱증적심리궤제.방법 장60례억욱증환자수궤분위저조항상태하적의념도입요법조(TIP조)화경추산서태보란편조(대조조),료정6개월,채용한밀이돈억욱량표(HAMD)평정료효,명니소체다항인격량표(MMPI)、오태인격량표평정작용궤제.결과 MMPI량표중의병[TIP조치료전후분별위(70.33±12.50)분、(60.45±11.94)분,대조조위(66.41±11.74)분、(57.95±11.66)분]、억욱[TIP조치료전후분별위(71.62±8.81)분、(61.45±11.13)분,대조조위(66.75±12.34)분、(54.75±11.80)분]、억병[TIP조치료전후분별위(71.75±8.32)분、(64.87±8.58)분,대조조위(67.70±9.51)분、(59.33±9.89)분]、정신병태[TIP치료전후분별위(69.41±10.31)분、(60.70±13.19)분,대조조위(62.83±12.93)분、(56.04±12.39)분]、편집[TIP조치료전후분별위(60.16±7.64)분、(53.83±7.92)분,대조조위(58.79±12.88)분、(51.48±10.46)분]、정신쇠약[TIP조치료전후분별위(70.91±9.07)분、(63.45±9.53)분,대조조위(64.58±10.91)분、(53.25±15.64)분]、정신분렬[TIP조치료전후분별위(64.08±12.28)분、(58.70±12.55)분,대조조위(58.75±14.93)분、(51.95±11.89)분]유현저개선작용.경추산서태보란편재개선MMPI량표중정신쇠약、정신분렬(TPt=2.484、P=0.021;TSc=2.099、P=0.047)이급오태인격중태양형、소양형인격(T태양=-2.175、P=0.040;T소양=-2.066、P=0.049)방면우우TIP조.결론 TIP치료억욱증적심리궤제재우개선MMPI량표중의병、억욱、억병、정신병태、편집、정신쇠약、정신분렬인자.
Objective To observe the psychological mechanism of Low Resistance Thought Induction Psychotherapy (TIP) on depression.Methods 60 patients with depression were randomly divided into a TIP group and a citalopram group.The observation period was 6 months.The Hamilton Rating Scale for Depression (HAMD) was used to evaluate the efficacy,and Minnesota Multiphasic Personality Inventory (MMPI) and Five Pattern Personality Inventory (FPPI) were used to evaluate the psychological mechanism.Results Both TIP and citalopram have efficacy on regulating Hs [TIP group before treatmen(70.33 ± 12.50),after treatment (60.45 ± 11.94) ; citalopram group before (66.41 ± 11.74),after treatment (57.95± 11.66)] ; D [TIP group before (71.62±8.81),after treatment(61.45± 11.13); citalopram group before (66.75± 12.34),after treatment (54.75± 11.80)] ; Hy [TIP group before (71.75±8.32),after treatment(64.87±8.58) ; citalopram group before(67.70±9.51),after treatment(59.33±9.89)],Pd [TIP group before (69.41± 10.31),after treatment (60.70± 13.19) ; citalopram group before (62.83 ± 12.93),after treatment (56.04± 12.39)]、Pa [TIP group before (60.16 ± 7.64),after treatment (53.83 ± 7.92) ; citalopram group before (58.79 ± 12.88),after treatment (51.48± 10.46)],Pt [TIP group before(70.91±9.07),after treatment(63.45±9.53); citalopram group before(64.58± 10.91) after treatment (53.25± 15.64)],Sc [TIP group before (64.08± 12.28),after treatment (58.70 ± 12.55) ; citalopram group before (58.75 ± 14.93),after treatment (51.95 ± 11.89)] of MMPI.Citalopram is superior to TIP on regulating PT、SC (TPt=2.484,P=0.021; TSc =2.099,P=0.047) of MMPI and Taiyang and Shaoyang (Ttaiyang=-2.175,P=0.040; Tshaoyang=-2.066,P=0.049) of FPPI.Conclusion The psychological mechanism of TIP treating depression was to regulating Hs D、Hy、Pd、Pa、Pt、Sc of MMPI.